CytoDyn to Hold Webcast and Live Q/A on October 26

Ads

You May Also Like

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

Closes on $30 Million Extension to Senior Credit Facility FT. MYERS, Fla., June 25, ...

Ultragenyx Reports Fourth Quarter 2015 and Full-Year 2015 Financial Results and Corporate Update

NOVATO, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical ...

RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D

The first patients have been dosed in the randomized, double-blind, placebo-controlled Phase II study ...